Risk of drug-induced cardiac arrhythmia during COVID-19 therapeutic treatment

Therapeutic treatment of severe COVID-19 infection involves the administration of multiple pharmacologic agents to reduce the risk of serious complications; this may result in drug interactions and possible adverse reactions and induced cardiotoxicity. The risk–benefit ratio associated with the use...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitiello, Antonio, Ferrara, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600338/
https://www.ncbi.nlm.nih.gov/pubmed/34792677
http://dx.doi.org/10.1186/s43044-021-00228-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600338/
https://www.ncbi.nlm.nih.gov/pubmed/34792677
http://dx.doi.org/10.1186/s43044-021-00228-8

Ejemplares similares